期刊文献+

利用载舒尼替尼的多聚体微泡实现超声介导的靶向药物运输:实验研究 被引量:4

Sunitinib loaded polymer microbubbles for ultrasound triggered drug delivery: An experimental study
下载PDF
导出
摘要 目的探索载舒尼替尼的新型多聚体型微泡抑制人肾癌GRC-1细胞增殖及诱导凋亡的作用。方法体外培养人肾癌GRC-1细胞,将其分为空白对照组、舒尼替尼组、新型多聚体型微泡联合超声组(pMB+US组)、载舒尼替尼的新型多聚体型微泡不联合超声组(pMBS-US组)、载舒尼替尼的新型多聚体型微泡联合超声组(pMBS+US组)。舒尼替尼组、pMBS-US组、pMBS+US组分别以0.01、0.10、1.00μg/ml舒尼替尼给予处理,于不同时间以MTT法观察不同处理组细胞生存率,检测细胞凋亡,并用HE染色法及DAPI荧光染色法观察凋亡细胞形态学改变。结果 pMBS+US组较之其余各组对肿瘤细胞有更为明显的抑制增殖及诱导凋亡效应(P<0.01)。结论载舒尼替尼的新型多聚体型微泡在超声作用下能显著促进药物与肿瘤细胞的作用,为靶向持续药物运输提供了可能。 Objective To investigate the effect of proliferation inhibition and apoptosis induction of sunitinib loaded poly- mer microbubbles on renal carcinoma cell strain GRC-I. Methods GRC-1 cell strain was cultured in vitro, and was divided into 5 groups, i.e. blank control group, sunitinib group (Sunitinib group), new polymer microbubbles with ultrasound group (pMB+ US group), sunitinib loaded polymer microbuhbles without ultrasound group (pMBS--US group) and sunitinib loaded polymer microbubbles with ultrasound group (pMBS+ US group). Sunitinib group, pMBS--US group, pMBS+ US group were pretreated with various concentration drugs (0.01, 0.10, 1.00 μg/ml). MTT method was used to observe the cell survival rates of different treatment groups by changing the drug concentration. HE staining and DAPI flu- orescent staining were employed to detect apoptosis. Results The tumoricidal activity and apoptosis induction of pMBS+ US group was significantly greater than that in other groups (P〈0, 01). Conclusion Sunitinib loaded polymer microbub- bles can enhance drug delivery to tumor cells when triggered with focused ultrasound, which have potential value to provide a targeted and sustained delivery of drug to tumors.
出处 《中国医学影像技术》 CSCD 北大核心 2013年第2期161-164,共4页 Chinese Journal of Medical Imaging Technology
基金 国家自然科学基金面上项目(81071875)
关键词 造影剂 超声检查 微泡 舒尼替尼 靶向药物运输 Contrast media Ultrasonogarphy Microbubbles Sunitinib Targeted drug delivery
  • 相关文献

参考文献9

  • 1Eisenbrey JR,Huang P,Hsu J. Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents[J].Ultrasonics,2009,(08):628-633.doi:10.1016/j.ultras.2009.03.003.
  • 2Ferrara K,Pollard R,Borden M. Ultrasound microbubble contrast agents:Fundamentals and application to gene and drug delivery[J].Annual Review of Biomedical Engineering,2007.415-447.
  • 3Ferrara KW. Driving delivery vehicles with ultrasound[J].Advanced Drug Delivery Reviews,2008,(10):1097-1102.doi:10.1016/j.addr.2008.03.002.
  • 4Ferrara KW,Borden MA,Zhang H. Lipid-shelled vehicles:Engineering for ultrasound molecular imaging and drug delivery[J].Accounts of Chemical Research,2009,(07):881-892.
  • 5Kuijpers MA,Iedema PD,Maartje FK. The mechanism of cavitation-induced polymer scission;experimental and computational verification[J].Polymer (Guildf),2004,(19):6461-6467.doi:10.1016/j.polymer.2004.06.051.
  • 6Hernot S,Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery[J].Advanced Drug Delivery Reviews,2008,(10):1153-1166.doi:10.1016/j.addr.2008.03.005.
  • 7Epstein-Barash H,Orbey G,Polar BE. A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery[J].Biomaterials,2010,(19):5208-5217.
  • 8Klibanov AL,Shevchenko TI,Raju BI. Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs:A tool for targeted drug delivery[J].Journal of Controlled Release,2010,(01):13-17.
  • 9Cochran MC,Eisenbrey J,Ouma RO. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery[J].International Journal of Pharmaceutics,2011,(1-2):161-170.

同被引文献53

  • 1查月琴,沈卫东,林和平,沈玲玲,陈卫国,王阿军,侯建全.经直肠超声造影灌注方式在前列腺良恶性病变中的初步研究[J].中国血液流变学杂志,2008,18(4):601-603. 被引量:12
  • 2张雪娇,程永清,李丽君,王小荣.包膜微泡超声造影剂的研究进展[J].中国医学影像技术,2005,21(5):819-821. 被引量:17
  • 3杨春江,王志刚,李兴升,郑元义,冉海涛,许川山,彭晓琼,李攀,苏琳.载药脂质微气泡的制备及其应用[J].中华超声影像学杂志,2006,15(7):535-538. 被引量:28
  • 4NICOLAU C,BRU C.Focal liver lesions :evaluation withcontrast-enhanced ultrasonography [ J] .Abdom Imaging,2004,29(3):348-359.
  • 5KABAKCI N,IGCI E,SECIL M,et al.Echo contrast-enhancedpower doppler ultrasonography for assessment of angiogenesis inrenal cell carcinoma[ J] .J Ultrasound Med,2005 ,24(6):747-753.
  • 6FRAUSCHER F,ALLWEIN L,K1AUSER A,et al.Ultrasoundcontrast agents and prostate cancer[ J].Radiologe,2005,45(6):544-551.
  • 7DAMBER JE,AUS G.Prostate cancer [ J].Lancet,2008,371(9625):1710-1721.
  • 8PALLWEIN L,MITTERBERGER M,GRADL J,et al.Value ofcontrast-enhanced ultrasound and elastography in imaging ofprostate cancer[ J].J Curr Opin Urol,2007 ,17(1 ):39-47.
  • 9PALLWEIN L,MITTERBERGER M,PELZER A,et al.Ultrasound of prostate cancer :recent advances [ J].Eur Radiol,2008,18(4):707-715.
  • 10WINK MH,DE LA ROSETTE JJ,GRIMBERGEN CA,et al.Transrectal contrast enhanced ultrasound for diagnosis of prostatecancer[J].World J Urol,2007,25(4):367-373.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部